Our site uses cookies to offer a better navigation functionality, including "third party" cookies and "profiling cookies" designed to send on-line commercial communications in line with the preferences expressed by the user while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here to disable them. Upon proceeding with browsing this website, you will be consenting to the use of cookies.

Respiratory Area - Under Prescription Drugs

Brand name

Active ingredient

Therapeutic class

Packaging

Reimbursement class

MA number

ALIFLUS 25/250

salmeterol xinafoate 50 mcg + fluticasone propionate 250 mcg/dose

Antiasthmatic and COPD

1 dispenser - 120 doses

A

034463125

ALIFLUS 25/125

salmeterol xinafoate 50 mcg + fluticasone propionate 125 mcg/dose

Antiasthmatic and COPD

1 dispenser - 120 doses

A

034463113

ALIFLUS 25/50

salmeterol xinafoate 50 mcg + fluticasone propionate 50 mcg/dose

Antiasthmatic and COPD

1 dispenser - 120 doses

A

034463101

ALIFLUS DISKUS 50/500

salmeterol xinafoate 50 mcg + fluticasone propionate 500 mcg/dose

Antiasthmatic and COPD

1 dispenser - 60 doses

A

034463063

ALIFLUS DISKUS 50/250

salmeterol xinafoate 50 mcg + fluticasone propionate 250 mcg/dose

Antiasthmatic and COPD

1 dispenser - 60 doses

A

034463051

ALIFLUS DISKUS 50/100

salmeterol xinafoate 50 mcg + fluticasone propionate 100 mcg/dose

Antiasthmatic and COPD

1 dispenser - 60 doses

A

034463048

LAVENTAIR ELLIPTA 55/22 Umeclidinium 55mcg + Vilanterol 22mcg/dose Treatment of COPD 1 inhaler of 30 doses (One inhalation once daily) A - PT EU/1/14/899/002
REVINTY ELLIPTA 92/22 Fluticasone Furoate 92mcg + Vilanterol 22mcg/dose Treatment of Asthma and COPD 1 inhaler of 30 doses (One inhalation once daily) A 043446020/E
REVINTY ELLIPTA 184/22 Fluticasone Furoate 184mcg + Vilanterol 22mcg/dose Treatment of Asthma 1 inhaler of 30 doses (One inhalation once daily) A 043446057/E

Diagnostics

 

Advanced Technology

READ MORE »

Biotech

 

Menarini has been the Italian leader in the biotech industry for 30 years.

READ MORE »

Innovation and Research

 

Constant commitment to new drug research.

READ MORE »

Quality first

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »